Ledge Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ledge Wealth Management's PFE Position: Q2 2023 in Review
Ledge Wealth Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 6,294 shares — an estimated $257K sold.
Ledge Wealth Management first reported a position in PFE in Q1 2022 and held it in 5 quarters. The position peaked at $392K in Q2 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Ledge Wealth Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
- Ledge Wealth Management sold 6,294 Pfizer shares in Q2 2023, an estimated $257K.
- Ledge Wealth Management first reported a position in Pfizer in Q1 2022 and held it in 5 quarters.
- Ledge Wealth Management's Pfizer position peaked at $392K in Q2 2022.
- 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Ledge Wealth Management's 13F filing for Q2 2023, filed 12 Jul 2023.